Team
Zahra Jawad
Firestarter
Zahra is the founder of Creasallis, and she started the company in 2021 after having a sudden realisation on how to improve the penetration of antibodies into the tumour. She has 18 years’ experience in biotech/pharma in the Cambridge sphere, ranging from Domantis, GSK, LifeArc and Agenus. Her expertise is taking molecules from chaos to candidate, and delivering antibody therapeutics to IND. In addition to this, she has lead platform innovation groups and is looking to build a unique organisation in Creasallis, both in terms of growing and fostering innovation and exploring alternative ways of working to create an inspired and productive culture.
Catherine Goodrich
People Alchemist
Catherine has worked in the People & Culture function over the last 20 years across various countries and brings a wealth of experience including 8 years in biotech start-ups. She is an experienced HR Leader, Coach, Business Partner, and Implementer. She’s seen the good, the bad and the ugly, and this has led her to explore new ways of working. She claims to have the biggest personal library around this field.
Catherine will be leading our people and culture function with a focus on employee experience.
Nicola Ramsay
Antibody Artiste
With over 20 years of experience across biotech, pharma, and academia, Nicola brings deep expertise and infectious curiosity to everything she does. Her passion for exploring uncharted scientific territory fuels her love for protein engineering, particularly in the discovery and refinement of antibodies and antibody-like molecules.
Nicola specializes in isolating and engineering these complex proteins, guiding them from early-stage discovery through to candidate nomination with both precision and creativity.
Nicola heads the Protein Engineering function and is excited to have the opportunity to be shaping both the science and culture at Creasallis.
Silvia Mele
Biology Commander
Silvia has been working in translational research in biotech/pharma and academia for over 10 years. Her work has focussed on elucidating the drug mechanism(s) of action and molecular pathways, particularly for antibody-based therapeutics in oncology and inflammatory diseases. Her passion is understanding the underlaying logic, her favourite book? The book of whys! Silvia joined Creasallis in October 2024, and she is heading the Biology function with a focus on de-risking projects to develop a successful translational strategy.